전립선암 진단을 위한 바이오마커 패널
A Panel of Serum Biomarkers for Diagnosis of Prostate Cancer
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Cancer biomarkers are using in the diagnosis, staging, prognosis and prediction of disease progression. But, there are not sufficiently profiled and validated in early detection and risk classification of prostate cancer. In this study, we have devoted to finding a panel of serum biomarkers that are able to detect the diagnosis of prostate cancer. The serum samples were consisted of 111 prostate cancer and 343 control samples and examined. Eleven biomarkers were constructed in this study, and then nine biomarkers were relevant to candidate biomarkers by using t test. Finally, four biomarkers, PSA, ApoA2, CYFRA21.1 and TTR, were selected as the prostate cancer biomarker panel, logistic regression was used to identify algorithms for diagnostic biomarker combinations(AUC = 0.9697). A panel of combination biomarkers is less invasive and could supplement clinical diagnostic accuracy.
Abstract
Cancer biomarkers are using in the diagnosis, staging, prognosis and prediction of disease progression. But, there are not sufficiently profiled and validated in early detection and risk classification of prostate cancer. In this study, we have devoted to finding a panel of serum biomarkers that are able to detect the diagnosis of prostate cancer. The serum samples were consisted of 111 prostate cancer and 343 control samples and examined. Eleven biomarkers were constructed in this study, and then nine biomarkers were relevant to candidate biomarkers by using t test. Finally, four biomarkers, PSA, ApoA2, CYFRA21.1 and TTR, were selected as the prostate cancer biomarker panel, logistic regression was used to identify algorithms for diagnostic biomarker combinations(AUC = 0.9697). A panel of combination biomarkers is less invasive and could supplement clinical diagnostic accuracy.
참고문헌 (10)
- Jemal A, "Global cancer statistics", Ca-A Cancer Journal For Clinicians, 61(2), pp.69~90 (2011)
- Boyle P, "Cancer incidence and mortality in Europe, 2004", Annals of Oncology, 16(3), pp.481~488 (2005)
- Quinn M, "Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part I : international comparisons", BJU International, 90(2), pp.174~184 (2002)
- Parkin DM, "Cancer burden in the year 2000. The global picture", European Journal of Cancer, 37(8), pp.4~66 (2001)
- Jaeryun Lee, "The Clinical Lecture _ Guidelines of Cancer Care for general practitioner : Prostate Cancer", Korean Journal of Internal Medicine Autumn, 2013(2), pp.116~120 (2013)
- Smith DS, "Interexaminer variability of digital rectal examination in detecting prostate cancer", Urology, 45(1), pp.70~74 (1995)
- Chodak GW, "Assessment of screening for prostate cancer using the digital rectal examination", Journal of Urology, 41(5), pp.1136~1138 (1989)
- Cooperberg MR, "Contemporary trends in low risk prostate cancer : risk assessment and treatment", Journal of Urology, 178(3), pp.14~19 (2007)
- Schröder FH1, "Screening and prostate-cancer mortality in a randomized European study", The New England Journal of Medicine, 360(13), pp.1320~1328 (2009)
- R Development Core Team, "A Language and Environment for Statistical Computing" (2007), R Foundation for Statistical Computing